|
NGDN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.723400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.068800E-01 |
| Normal-vs-Stage2 |
2.814400E-01 |
| Normal-vs-Stage3 |
8.307200E-01 |
| Normal-vs-Stage4 |
9.175400E-01 |
| Stage1-vs-Stage2 |
1.488950E-01 |
| Stage1-vs-Stage3 |
8.573200E-01 |
| Stage1-vs-Stage4 |
9.146600E-01 |
| Stage2-vs-Stage3 |
3.234600E-01 |
| Stage2-vs-Stage4 |
5.438600E-01 |
| Stage3-vs-Stage4 |
9.767000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.365800E-01 |
| Normal-vs-AfricanAmerican |
7.304600E-01 |
| Normal-vs-Asian |
5.995600E-01 |
| Caucasian-vs-AfricanAmerican |
8.764000E-01 |
| Caucasian-vs-Asian |
6.030600E-01 |
| AfricanAmerican-vs-Asian |
6.575400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.103600E-01 |
| Normal-vs-Female |
2.631400E-01 |
| Male-vs-Female |
1.346180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.643800E-01 |
| Normal-vs-Extreme_Weight |
9.584400E-01 |
| Normal-vs-Obese |
9.565200E-01 |
| Normal-vs-Extreme_Obese |
1.561850E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.864400E-01 |
| Normal_Weight-vs-Obese |
7.259400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.495200E-01 |
| Extreme_Weight-vs-Obese |
9.043400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.869380E-01 |
| Obese-vs-Extreme_Obese |
2.576600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.624000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.403200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.337400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.097800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.883450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.074400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.792390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.035600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.928400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.369400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.804800E-01 |
| Normal-VS-Type2 PRCC |
1.667760E-01 |
| Normal-VS-KIRP CIMP |
8.466400E-01 |
| Normal-VS-Unclassified PRCC |
9.984500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.189500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.369800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.590100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.123400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.290000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.078200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.908300E-02 |
| Normal-vs-N1 |
9.414100E-02 |
| Normal-vs-N2 |
1.391720E-02 |
| N0-vs-N1 |
8.884000E-03 |
| N0-vs-N2 |
1.567380E-01 |
| N1-vs-N2 |
4.551500E-02 |
|
|
